Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Early research (Phase 1)Study completedNCT00093821
What this trial is testing

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)UnknownNCT03420014
What this trial is testing

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Who this might be right for
Leiomyosarcoma
Philogen S.p.A. 114
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT03013127
What this trial is testing

Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery

Who this might be right for
Osteosarcoma
Oslo University Hospital 12
Testing effectiveness (Phase 2)Temporarily pausedNCT00079950
What this trial is testing

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Enzon Pharmaceuticals, Inc.
Early research (Phase 1)Looking for participantsNCT06235125
What this trial is testing

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Who this might be right for
OsteosarcomaPulmonary MetastasisFluorescence+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Looking for participantsNCT07153887
What this trial is testing

Vebreltinib for Advanced or Metastatic CCS

Who this might be right for
Clear Cell Sarcoma (CCS)
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Early research (Phase 1)Active Not RecruitingNCT00902044
What this trial is testing

Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma

Who this might be right for
Sarcoma
Baylor College of Medicine 36
Large-scale testing (Phase 3)Study completedNCT00003937
What this trial is testing

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
Children's Oncology Group 253
Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6
Very early researchWithdrawnNCT04877587
What this trial is testing

Gemcitabine With Ascorbate Including Adolescents

Who this might be right for
Soft Tissue SarcomaBone SarcomaUnresectable Soft Tissue Sarcoma+3 more
David Dickens
Testing effectiveness (Phase 2)Ended earlyNCT03660930
What this trial is testing

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma
University of Washington 19
Testing effectiveness (Phase 2)Study completedNCT01259375
What this trial is testing

Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Utah 24
Testing effectiveness (Phase 2)Ended earlyNCT04579757
What this trial is testing

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorColorectal CancerNeuroendocrine Tumors+4 more
Hutchmed 87
Testing effectiveness (Phase 2)Study completedNCT01574716
What this trial is testing

Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

Who this might be right for
Metastatic Soft Tissue Sarcoma
Morphotek 209
Not applicableUnknownNCT00514345
What this trial is testing

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Who this might be right for
Chemotherapeutic Agent ToxicitySarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04874311
What this trial is testing

Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
Institut Bergonié 80
Testing effectiveness (Phase 2)Study completedNCT00643565
What this trial is testing

Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Who this might be right for
Sarcoma
Hoffmann-La Roche 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT04028063
What this trial is testing

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Who this might be right for
Metastatic Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma
University of Colorado, Denver 65
Next Page